TWC
HZNP

TD Waterhouse Canada’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

TD Waterhouse Canada’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,691
Closed -$428K – 1830
2023
Q3 		$428K Sell
3,691
-1,480
-29% -$159K ﹤0.01% 536
2023
Q2 		$532K Sell
5,171
-122
-2% -$12.9K 0.01% 521
2023
Q1 		$576K Sell
5,293
-153
-3% -$16.9K 0.01% 508
2022
Q4 		$618K Sell
5,446
-21
-0.4% -$1.74K 0.01% 487
2022
Q3 		$351K Sell
5,467
-6,716
-55% -$469K ﹤0.01% 576
2022
Q2 		$985K Buy
12,183
+11,058
+983% +$1.05M 0.01% 413
2022
Q1 		$121K Buy
1,125
+600
+114% +$58.5K ﹤0.01% 819
2021
Q4 		$55.8K Buy
+525
New +$57.3K ﹤0.01% 980

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TD Waterhouse Canada's HZNP Position: Q4 2023 in Review

TD Waterhouse Canada sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,691 shares — an estimated $428K sold.

TD Waterhouse Canada first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $985K in Q2 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • TD Waterhouse Canada reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • TD Waterhouse Canada sold 3,691 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $428K.
  • TD Waterhouse Canada first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
  • TD Waterhouse Canada's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $985K in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on TD Waterhouse Canada's 13F filing for Q4 2023, filed 12 Feb 2024.